Compared with albuterol rescue alone (180 mcg), the combination albuterol-budesonide inhaler (180 mcg and 160 mcg, respectively) resulted in a significant reduction in the risk of a severe ...

Results from the pivotal BATURA trial show that Airsupra (albuterol/budesonide) significantly outperformed albuterol ...

For patients treated with AIRSUPRA 180 mcg/160 mcg the annualized total systemic corticosteroids dose when compared with albuterol 180 mcg was statistically significantly different, with a ...

These patients were randomly assigned to receive either 180 micrograms (mcg) of albuterol and 160 mcg of budesonide, 180 mcg of albuterol and 80 mcg of budesonide, 180 mcg of albuterol ...

Participants were randomly assigned in a 1:1 ratio to a fixed-dose combination of 180 μg of albuterol and 160 μg of budesonide (with each dose consisting of two inhaler actuations of 90 μg and ...

A pharmaceutical company has recalled six batches of albuterol sulfate inhalers after a complaint from one patient that the inhaler leaked. Cipla US is voluntarily recalling the 90 mcg inhalers ...

Cipla voluntarily recalled six batches of albuterol sulfate inhalation aerosol 90 mcg after a leak was identified. The manufacturer recommends to stop using products affected by the recall.

and hereafter referred to as "Cipla"), today announced that its wholly-owned subsidiary Cipla US is voluntarily recalling six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered ...

There were no adverse events reported for Albuterol Sulfate Inhalation Aerosol 90 mcg related to this recall. The company is initiating a recall in the US due to a market complaint for one single ...